Fragment-based approaches to TB drugs
- 2 November 2016
- journal article
- conference paper
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 145 (2) , 184-195
Abstract
SUMMARY: Tuberculosis is an infectious disease associated with significant mortality and morbidity worldwide, particularly in developing countries. The rise of antibiotic resistance in Mycobacterium tuberculosis (Mtb) urgently demands the development of new drug leads to tackle resistant strains. Fragment-based methods have recently emerged at the forefront of pharmaceutical development as a means to generate more effective lead structures, via the identification of fragment molecules that form weak but high quality interactions with the target biomolecule and subsequent fragment optimization. This review highlights a number of novel inhibitors of Mtb targets that have been developed through fragment-based approaches in recent years.Keywords
This publication has 46 references indexed in Scilit:
- A structure-guided fragment-based approach for the discovery of allosteric inhibitors targeting the lipophilic binding site of transcription factor EthRBiochemical Journal, 2014
- Inhibition ofMycobacterium tuberculosisTransaminase BioA by Aryl Hydrazines and HydrazidesChemBioChem, 2014
- Design and Synthesis of Potential Mechanism-Based Inhibitors of the Aminotransferase BioA Involved in Biotin BiosynthesisThe Journal of Organic Chemistry, 2012
- Fragment-Based Approaches in Drug Discovery and Chemical BiologyBiochemistry, 2012
- Dynamic Substrate Enhancement for the Identification of Specific, Second‐Site‐Binding Fragments Targeting a Set of Protein Tyrosine PhosphatasesChemBioChem, 2011
- Ethionamide Boosters: Synthesis, Biological Activity, and Structure−Activity Relationships of a Series of 1,2,4-Oxadiazole EthR InhibitorsJournal of Medicinal Chemistry, 2011
- Recent Developments in Fragment-Based Drug DiscoveryJournal of Medicinal Chemistry, 2008
- Coenzyme A biosynthesis: an antimicrobial drug targetFEMS Microbiology Reviews, 2008
- Crystal Structure of the TetR/CamR Family Repressor Mycobacterium tuberculosis EthR Implicated in Ethionamide ResistanceJournal of Molecular Biology, 2004
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998